About Cobio
The Company and Team
Cobio’s business model focuses on simplicity and time-to-market expediency through 1) the preferred method of strategic partnering and licensing with an established medical diagnostics company or 2) through 3rd party contract manufacturing and distribution.
In both alternatives, the R&D team will remain lean and will be focused on the development and production of phage cocktails and anti-phage capture and detection antibodies while leveraging relationships to manufacture, sell, and distribute products. Cobio is a Colorado corporation that meets the eligibility requirements set forth by the NSF.
Dr. Andy Logan
Day-to-day operations are led by Dr. Andy Logan. With a background in microbiology and environmental engineering, Andy has been working with startup companies for 20+ years where he has been an inventor, co-founder, and has raised over $40M in venture capital.
Dr. Chris Cox
Cobio’s Lead Scientific Advisor is Dr. Chris Cox. Chris is an inventor of Cobio’s technology and applies his background in molecular biology and virology to leading the development of Cobio’s technology platform.
Advisory Team
Cobio’s Advisory Team includes a Professor of Molecular Biology and a team of Infectious Disease Physicians from the University of Colorado and The Children’s Hospital of Colorado.